News
The findings, which add to the limited data on the burden of atopic dermatitis on adolescent and pediatric patients, showed ...
ILC accounts for 10–15% of breast cancers and often goes undetected. Learn about its characteristics, treatments, and future ...
Realizing their options for medically assisted death are so far limited in New York, a Catskills couple decided to seek it in Oregon.
The FDA is likely to approve the first treatment for smoldering multiple myeloma but pass on a new option relapsed/refractory DLBCL, after votes by its Oncologic Drugs Advisory Committee.
Margrit Wiesendanger, MD, PhD, discusses how lupus treatment is evolving from traditional therapies to more targeted options like biologics, with promising advances now being explored in clinical ...
Learn the signs of pancreatic cancer including unexplained weight loss, distinctive pain patterns, digestive changes, and ...
The Idaho Transportation Department is closing in on its future vision for Highway 44 through Middleton after decades of ...
The Crossroads Center is set to move to a new 29,000-square-foot facility on Reading Road, expanding its mental health and addiction recovery services.
Up to 40% of all epilepsy diagnoses in the United States are of the drug-resistant variety, affecting 1.2 million people ...
The story of chronic itch and its impact on quality of life is one dermatologists have heard often. Until recently, treatment ...
Throughout history, humans have pursued many ambitious goals: exploring distant lands, seeking wealth, and finding solutions to persistent health problems—like hair loss. From ancient Egyptian ...
In light of former President Biden's prostate cancer diagnosis, retired journalist Jim Ware details his own journey.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results